Trazodone does not treat opioid withdrawal itself, but it can significantly improve one of withdrawal’s most persistent and disruptive symptoms: insomnia. In a double-blind, placebo-controlled trial of opioid-dependent patients, 82% of those taking trazodone achieved normal sleep quality scores after six weeks, compared to just 16% on placebo. While trazodone won’t ease the muscle aches, nausea, or cravings that define opioid withdrawal, its ability to restore sleep can make the process considerably more manageable.
Why Sleep Problems Are Central to Opioid Withdrawal
Opioids fundamentally alter the brain’s sleep architecture. When you stop taking them, the rebound effect hits sleep especially hard. Most people going through withdrawal report difficulty falling asleep, frequent nighttime awakenings, and sleep that feels shallow and unrestorative. These problems often persist for weeks or even months after the acute physical symptoms like sweating, diarrhea, and restlessness have faded.
Poor sleep during withdrawal isn’t just uncomfortable. It drives relapse. When you’re exhausted, your ability to cope with cravings and emotional distress drops sharply. That makes treating insomnia during this period more than a comfort measure; it’s a practical strategy for staying on track with recovery.
How Trazodone Works for Withdrawal Insomnia
Trazodone is an older antidepressant that, at lower doses, acts primarily as a sedative. It works by blocking certain serotonin receptors and histamine receptors in the brain, which promotes drowsiness without the habit-forming risk that comes with benzodiazepines or sleep medications like zolpidem. This non-addictive profile is exactly why it’s attractive during opioid recovery, when prescribers are understandably cautious about introducing anything with abuse potential.
The clinical trial data on trazodone in opioid-dependent patients is encouraging. In the placebo-controlled study of patients stabilized on buprenorphine, trazodone at an average dose of about 100 mg per day improved multiple dimensions of sleep: how quickly people fell asleep, how long they stayed asleep, how efficient their sleep was, and how they rated their overall sleep quality. The improvements were dramatic compared to placebo, with a fivefold difference in the proportion of patients reaching normal sleep scores.
Subjective improvements tend to appear within the first one to two weeks of taking trazodone, though the full benefit builds over several weeks. One important caveat: studies have found that when trazodone is stopped, rebound insomnia can occur as early as the second night after discontinuation. This means tapering off gradually, rather than stopping abruptly, is the better approach.
What Trazodone Does Not Do
Trazodone is not a substitute for medications that directly address opioid withdrawal and cravings, such as buprenorphine or methadone. It doesn’t reduce the physical symptoms of withdrawal like muscle pain, gastrointestinal distress, or the intense restlessness that peaks in the first few days. It also doesn’t block cravings. Think of it as a targeted tool for one specific, stubborn symptom rather than a comprehensive withdrawal treatment.
Some early research explored using trazodone at much higher doses (up to 800 mg daily) as part of rapid withdrawal protocols alongside naltrexone, essentially pairing it with clonidine alternatives. But those high-dose approaches are distinct from the more common practice of using low-dose trazodone (50 to 150 mg) specifically for sleep.
Trazodone With Buprenorphine or Methadone
Many people going through opioid withdrawal or in medication-assisted treatment are already taking buprenorphine or methadone. The clinical trial evidence specifically studied trazodone in patients stabilized on buprenorphine and found it was well tolerated alongside that medication. Patients in the trial took 50 to 150 mg of trazodone at bedtime without significant safety concerns over the six-week study period.
That said, both trazodone and opioid medications can cause sedation, and combining sedating drugs always warrants caution. The risk of excessive drowsiness or slowed breathing increases when multiple sedating substances are used together, particularly if alcohol is also involved. Your prescriber will typically start at the lower end of the dose range and adjust based on how you respond.
How It Compares to Other Sleep Aids
During opioid withdrawal, the options for treating insomnia are limited by the need to avoid anything addictive. That rules out the most commonly prescribed sleep medications. The realistic alternatives are trazodone, certain antipsychotics used off-label for sleep (like quetiapine), and over-the-counter antihistamines.
Compared to quetiapine, trazodone appears to cause fewer nighttime awakenings in psychiatric inpatient populations (roughly 0.5 awakenings per night versus 0.75). However, trazodone carries a higher rate of gastrointestinal side effects, including nausea, constipation, and diarrhea, which is worth noting since opioid withdrawal already involves significant GI distress.
Over-the-counter antihistamines like diphenhydramine are widely used for sleep, but they come with side effects that can be problematic during withdrawal. They cause dry mouth, urinary retention, and cognitive fogginess, and they tend to lose effectiveness quickly with repeated use. Trazodone generally maintains its sleep benefits over a longer period, making it the more practical choice for the weeks-to-months timeline of post-withdrawal insomnia.
Common Side Effects
At the low doses used for sleep (50 to 150 mg), trazodone’s side effects are generally mild. The most frequently reported issues include morning grogginess, dry mouth, dizziness, and nausea. The GI side effects overlap with withdrawal symptoms, which can make it hard to tell what’s causing what in the early days.
A rare but well-known side effect in men is priapism, a prolonged, painful erection that requires emergency treatment. It’s uncommon enough that it shouldn’t discourage use, but it’s worth being aware of. Most people tolerate trazodone well, and in clinical trials involving opioid-dependent patients, dropout rates due to side effects were low.
What to Realistically Expect
If you’re prescribed trazodone during opioid withdrawal or early recovery, expect it to take the edge off your insomnia within the first week or two, with continued improvement over the following month. It won’t knock you out the way a benzodiazepine would, and your sleep may still not feel entirely normal, but the difference between sleeping four broken hours and getting six or seven hours of more continuous rest is significant for both your mood and your ability to function during the day.
Trazodone also has mild anxiolytic properties. In studies of post-withdrawal patients (including alcohol withdrawal, which shares overlapping symptoms with opioid withdrawal), patients on trazodone scored better on anxiety and overall clinical improvement scales than those on placebo. This secondary benefit is modest, but it adds to the overall picture of trazodone as a useful supportive medication during recovery, even if it’s not addressing the core withdrawal syndrome.